Delivery Order SPE2DB22D3102-SPE2DB26FK8RU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a fulfillment under AmerisourceBergen's existing Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Cephalexin 250 mg capsules in quantities of 500 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,456.96 and is scheduled for completion by August 11, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency Troop Support Medical awarded a $188,530 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of 500mg cephalexin antibiotics. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 26, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle....
- The Defense Logistics Agency awarded a $147 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of 500mg Cephalexin antibiotic. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle and has a period of performance from August 1st through August 2nd, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $1,562.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of 500mg cephalexin antibiotic. The order was placed under an existing prime vendor contract vehicle to support DLA pharmaceutical procurement needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from September 1st through September 5th, 2023. No subcontractors or set aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,935.96 to AmerisourceBergen Drug Corp for the supply of Cephalexin 250 mg/5 mL suspension in 200 mL quantities. The award, issued on September 3, 2025, represents a firm fixed price, competitively awarded contract with an ultimate completion date of September 4, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,314,953 units of Cephalexin 500 mg capsules. The contract has a firm fixed price of $4,979.51 and a performance period that runs through August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- The Defense Logistics Agency awarded a $178,760 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of 500mg Cephalexin antibiotics. The contract has a period of performance from June 29, 2023 through June 30, 2023, with all products to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the U.S....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Cephalexin Capsules, valued at $12,321.33 with a firm fixed price structure. This non-set-aside contract is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's role as a critical pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a $163,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 456,164580 capsules of cephalexin. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements. The order is to be completed within a single day between August 1st and 2nd, 2023. Amerisourcebergen Corporation is...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB26FK8RUDelivery Order
The Defense Logistics Agency awarded a $1,141.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 capsules of Cephalexin 500 mg, a commonly prescribed antibiotic medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 24, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with a portfolio encompassing specialty medications, vaccines, generic drugs, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/23/25 |